Chemokines and hepatocellular carcinoma

被引：57
|
作者：
Huang, Fan [1 ]
Geng, Xiao-Ping [1 ]
机构：
[1] Anhui Med Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Hefei 230022, Anhui, Peoples R China
来源：
WORLD JOURNAL OF GASTROENTEROLOGY | 2010年 / 16卷 / 15期
关键词：
Chemokines; Hepatocellular carcinoma; FACTOR-I; RECEPTOR CXCR4; HEPATOMA-CELLS; NONSMALL CELL; EXPRESSION; CANCER; LIVER; LIGAND; GROWTH; INFLAMMATION;
D O I：
10.3748/wjg.v16.i15.1832
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Chemokines play a paramount role in tumor progression. In hepatocellular carcinoma (HCC) progression, chemokines and their receptors play an intricate role. Currently, chemokines and their receptors such as the CXCL12-CXCR4 axis, CX3CL1-CX3CR1 axis and the CCL20-CCR6 axis have received much research attention. Although a large number of studies show that these axes are strongly associated with HCC, the exact mechanism by which these axes promote the growth and progression of HCC remains unknown. In this paper, several chemokines and their receptor interactions in HCC progression, growth and metastasis and immune response to HCC are reviewed. (C) 2010 Baishideng. All rights reserved.
引用
收藏
页码：1832 / 1836
页数：5
相关论文
共 50 条
  • [21] Transcriptomic analyses of chemokines reveal that down-regulation of XCR1 is associated with advanced hepatocellular carcinoma
    Wang Yanru
    Bai Zhenyu
    Niu Zhengchuan
    Qi Qi
    Liang Chunmin
    Yao, Weiqiang
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 496 (04) : 1314 - 1321
  • [22] Serum levels of chemokines CCL4 and CCL5 in cirrhotic patients indicate the presence of hepatocellular carcinoma
    M Sadeghi
    I Lahdou
    H Oweira
    V Daniel
    P Terness
    J Schmidt
    K-H Weiss
    T Longerich
    P Schemmer
    G Opelz
    A Mehrabi
    British Journal of Cancer, 2015, 113 : 756 - 762
  • [23] Serum levels of chemokines CCL4 and CCL5 in cirrhotic patients indicate the presence of hepatocellular carcinoma
    Sadeghi, M.
    Lahdou, I.
    Oweira, H.
    Daniel, V.
    Terness, P.
    Schmidt, J.
    Weiss, K-H
    Longerich, T.
    Schemmer, P.
    Opelz, G.
    Mehrabi, A.
    BRITISH JOURNAL OF CANCER, 2015, 113 (05) : 756 - 762
  • [24] SERUM LEVELS OF CHEMOKINES CCL4 AND CCL5 IN CIRRHOTIC PATIENTS INDICATE THE PRESENCE OF HEPATOCELLULAR CARCINOMA
    Sadeghi, Mahmoud
    Lahdou, Imad
    Oweira, Hani
    Daniel, Volker
    Terness, Peter
    Schmidt, Jan
    Weiss, Karl-Heinz
    Longerich, Thomas
    Schemmer, Peter
    Opelz, Gerhard
    Mehrabi, Arianeb
    TRANSPLANT INTERNATIONAL, 2015, 28 : 412 - 412
  • [25] Hypoxia and hepatocellular carcinoma: The therapeutic target for hepatocellular carcinoma
    Wu, Xiong-Zhi
    Xie, Guang-Ru
    Chen, Dan
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 (08) : 1178 - 1182
  • [26] Simultaneous occurrence of sarcomatoid hepatocellular carcinoma and hepatocellular carcinoma
    Huang, Zhaoqin
    Meng, Xiangjiao
    Liu, Qingwei
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2015, 11 (03) : 665
  • [27] Hepatocellular carcinoma in the common bile duct "Hepatocellular Carcinoma"
    Yigit, Taner
    Yigitler, Cengizhan
    Demiriz, Murat
    Arslan, Ismail
    Tufan, Turgut
    LIVER INTERNATIONAL, 2007, 27 (02) : 288 - 290
  • [28] Macrotrabecular Hepatocellular Carcinoma An Aggressive Subtype of Hepatocellular Carcinoma
    Jeon, Yejoo
    Benedict, Mark
    Taddei, Tamar
    Jain, Dhanpat
    Zhang, Xuchen
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2019, 43 (07) : 943 - 948
  • [29] Hepatocellular carcinoma
    Dawe, RS
    LANCET, 2004, 363 (9412): : 899 - 899
  • [30] Hepatocellular carcinoma
    Braun, Felix
    Schaefer, Jost Philipp
    Dobbermann, Henrike
    Becker, Thomas
    Linecker, Michael
    CHIRURGIE, 2022, 93 (07): : 635 - 643
12345